Cargando…

Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD

BACKGROUND: Inpatient admissions for chronic obstructive pulmonary disease (COPD) represent a significant economic burden, accounting for over half of direct medical costs. Reducing 30-day readmissions could save health care resources while improving patient care. Recently, the Patient Protection an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bollu, Vamsi, Ernst, Frank R, Karafilidis, John, Rajagopalan, Krithika, Robinson, Scott B, Braman, Sidney S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858026/ https://www.ncbi.nlm.nih.gov/pubmed/24353413 http://dx.doi.org/10.2147/COPD.S52557

Ejemplares similares

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
por: Ganapathy, Vaidyanathan, et al.
Publicado: (2017)

Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β(2)-Agonists
por: Bollu, Vamsi, et al.
Publicado: (2016)

One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD
por: Donohue, James F., et al.
Publicado: (2014)

A comparative study of efficacy and safety of arformoterol and salbutamol nebulization as rescue therapy in acute non-severe asthma
por: Das, Sibes K., et al.
Publicado: (2011)

Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment
por: Celli, Bartolome R, et al.
Publicado: (2019)

Role of arformoterol in the management of COPD
por: King, Paul
Publicado: (2008)

Is nebulized saline a placebo in COPD?
por: Khan, Shahina Y, et al.
Publicado: (2004)

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
por: Donohue, James F, et al.
Publicado: (2019)

Nebulized corticosteroids in the management of acute exacerbation of COPD
por: Gaude, G. S., et al.
Publicado: (2010)

A review of nebulized drug delivery in COPD
por: Tashkin, Donald P
Publicado: (2016)

Effectiveness of treatment with nebulized colistin in patients with COPD
por: Bruguera-Avila, Nuria, et al.
Publicado: (2017)

Nebulized Therapies in COPD: Past, Present, and the Future
por: Barjaktarevic, Igor Z, et al.
Publicado: (2020)

Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial
por: Donohue, James F, et al.
Publicado: (2018)

Factors Associated with Failure of Intermittent Nebulization with Short-Acting Beta-Agonists in Children with Severe Asthma Exacerbation
por: Kulalert, Prapasri, et al.
Publicado: (2020)

Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD
por: Siler, Thomas M., et al.
Publicado: (2021)

Effect of background long-acting beta(2)-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD
por: Kerwin, Edward M, et al.
Publicado: (2018)

Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers
por: Harris, Jamie C., et al.
Publicado: (2022)

Nebulized formoterol: a review of clinical efficacy and safety in COPD
por: Gross, Nicholas J, et al.
Publicado: (2010)

Maintenance Therapy with Nebulizers in Patients with Stable COPD: Need for Reevaluation
por: Terry, Paul D., et al.
Publicado: (2020)

Perceptions and Attitudes of Patients and Their Family Caregivers on Nebulization Therapy for COPD
por: Dumra, Harjit, et al.
Publicado: (2022)

Tracheobronchial nebulizer DIVO™
por: Kurnosov, Nikolay Efimovich, et al.
Publicado: (2015)

Nebulin no longer nebulous
por: Sedwick, Caitlin
Publicado: (2018)

Nebulized lipid nanoparticles
por: Horejs, Christine
Publicado: (2021)

Inhalation of Nebulized Fluids
Publicado: (1866)

Comparison of Nebulized Ketamine with Nebulized Magnesium Sulfate on the Incidence of Postoperative Sore Throat
por: Segaran, Sivakumar, et al.
Publicado: (2018)

Mesh nebulizer is as effective as jet nebulizer in clinical practice of acute asthma in children
por: SOYER, Özge, et al.
Publicado: (2019)

A Simple and Novel Modification of the Nebulization Mask to Improve Nebulization in the Supine Position
por: Kaushal, Ashutosh, et al.
Publicado: (2023)

Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD
por: Tashkin, Donald P., et al.
Publicado: (2021)

Physicochemical compatibility of fluticasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions
por: Kamin, Wolfgang, et al.
Publicado: (2007)

A US Time and Motion Pilot Study of Nebulized COPD Therapy in an Inpatient and a Long-Term Care Setting
por: De Cock, Erwin, et al.
Publicado: (2022)

Nebulized nitroglycerin in the emergency department
por: Ulloa, Nicolas A., et al.
Publicado: (2023)

Comparison of Nebulized Epinephrine to Albuterol in Bronchiolitis
por: Walsh, Paul, et al.
Publicado: (2008)

Nebulizer practices among paramedics in India
por: Guleria, Randeep J, et al.
Publicado: (2019)

Nebulized Lidocaine in COVID-19, An Hypothesis
por: Ali, Ziad A., et al.
Publicado: (2020)

Effect of 4% nebulized lignocaine versus 2% nebulized lignocaine for awake fibroscopic nasotracheal intubation in maxillofacial surgeries
por: Kumar, Lohith, et al.
Publicado: (2020)

MDI or nebulization in moderate to severe COVID-19 disease with COPD: which one is better?
por: Chilkoti, Geetanjali T., et al.
Publicado: (2021)

Topical airway anesthesia for awake fiberoptic intubation: Comparison between airway nerve blocks and nebulized lignocaine by ultrasonic nebulizer
por: Gupta, Babita, et al.
Publicado: (2014)

Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease
por: Leaker, Brian R, et al.
Publicado: (2015)

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate
por: Ohar, Jill A, et al.
Publicado: (2020)

Effectivness of Nebulized Budesonide for COPD Exacerbation Management in Emergency Department; a Randomized Clinical Trial
por: Aghili, Mehrad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hgd08ff2oebrqmve48s06g01ok